Back to Search
Start Over
Emerging role of BAD and DAD1 as potential targets and biomarkers in cancer.
- Source :
- Oncology Letters; Dec2021, Vol. 22 Issue 6, pN.PAG-N.PAG, 1p
- Publication Year :
- 2021
-
Abstract
- As key regulators of apoptosis, BAD and defender against apoptotic cell death 1 (DAD1) are associated with cancer initiation and progression. Multiple studies have demonstrated that BAD and DAD1 serve critical roles in several types of cancer and perform various functions, such as participating in cellular apoptosis, invasion and chemosensitivity, as well as their role in diagnostic/prognostic judgement, etc. Investigating the detailed mechanisms of the cancerous effects of the two proteins will contribute to enriching the options for targeted therapy, and may improve clinical treatment of cancer. The present review summarizes research advances regarding the associations of BAD and DAD1 with cancer, and a hypothesis on the feasible relationship and interaction mechanism between the two proteins is proposed. Furthermore, the present review highlights the potential of the two proteins as therapeutic targets and valuable diagnostic and prognostic biomarkers. [ABSTRACT FROM AUTHOR]
- Subjects :
- TUMOR markers
DRUG target
PROGNOSIS
CELL death
CANCER invasiveness
Subjects
Details
- Language :
- English
- ISSN :
- 17921074
- Volume :
- 22
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- Oncology Letters
- Publication Type :
- Academic Journal
- Accession number :
- 153608012
- Full Text :
- https://doi.org/10.3892/ol.2021.13072